Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes.

Dermatology and therapy

Disproportionality Analysis of Tirzepatide-Associated Ketoacidosis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety.

Obesity surgery

Inter-organ communication shapes human metabolic tissue states and resolves anti-diabetic drug response modes in a six-tissue microphysiological system.

bioRxiv : the preprint server for biology

[Semaglutide-induced acute-on-chronic liver failure: A case report and literature review].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi-Dose Pens.

Obesity (Silver Spring, Md.)

Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.

Diabetes, obesity & metabolism

Starvation ketosis following self-administered tirzepatide obtained via online services in a young woman later diagnosed with anorexia nervosa: a case report.

Journal of eating disorders

🚨 For those interested in PEPTIDES please read up: My goal is to TRAIN and EDUCATE as many medical professionals about the proper use of peptides over the next 5 years. I’m working behind the scenes on the legal and FDA-related availability but IMO that’s an inevitability. https://t.co/uo0l4QBLg9

Reptides currently has 47 peptides ranked from S-F S tier: Tirzepatide Semaglutide Retatrutide Liraglutide Tesamorelin HGH HCG GHK-Cu A tier: SS-31 PT-141 Sermorelin BPC-157 TB-500 CJC+Ipa blend CJC-1295 Ipamorelin BPC+TB blend Melanotan II KLOW GLOW B tier: Cagrisema

India’s GLP-1 market has exploded from ₹121 crore to ₹1,736 crore in four years. After semaglutide’s patent expiry on 20 March, 13 companies launched 26 brands within a week. Prices crashed from nearly ₹16,000 per month to as low as ₹1,290, with Glenmark pricing a weekly

$HIMS was sitting near $15 just a few months ago with sentiment at absolute lows. This is exactly where long-term conviction matters. The people who stuck with $HIMS through peak fear are already sitting on an 80%+ move, and I still think this is just the beginning. Remember,

The peptides with the most human clinical data, listed. Not results. Not anecdotes. Strictly human trial evidence. 1.Semaglutide (the “OG” GLP-1) GLP-1 receptor agonist. Quiets food noise, slows gastric emptying, drives significant weight loss. 2.Tirzepatide (the upgrade)

You already take a peptide, or know someone who does. Ozempic is a peptide. So is insulin. A peptide is just a short chain of amino acids, smaller than a protein, that the body uses to send signals. That one word now covers two very different worlds. On one side: more than two https://t.co/hwfSOZtleR

Most people still don't know there's an FDA approved GLP-1 pill for weight loss that requires no injection and no fasting, and the ones who do know are ignoring it for one reason, Because it's not a peptide. Foundayo, the brand name for orforglipron, was approved by the FDA in

Tadalafil users Airlines lost my bag, inside were my a few of my daily stack including; Tadalafil, Semaglutide & Tirzepatide, BPC-157, Thymosin Beta-4, CJC-1295 & Ipamorelin, Epithalon, GHK-Cu, Semax & Selank and DSIP. Luckily I still have most of my others. What do I do?